• 1
    Atillasoy EO, Berk PD. Extracorporeal liver support: historical background and critical analysis. In: LeeWM, WilliamsR, eds. Acute Liver Failure. Cambridge: Cambridge University Press, 1995: 22344.
  • 2
    Plevris JN, Schina M, Hayes PC. Review article: the management of acute liver failure. Aliment Pharmacol Ther 1998; 12: 40518.DOI: 10.1046/j.1365-2036.1998.00320.x
  • 3
    Murphy GM. Serum bile acids. In: SetchellKD, KritchevskyD, NairPP, eds. The Bile Acids, Vol. IV. Methods and Applications. New York: Plenum Press, 1988: 379403.
  • 4
    Azer SA, Klaassen CD, Stacey NH. Biochemical assay of serum bile acids: methods and applications. Br J Biomed Sci 1997; 54: 11832.
  • 5
    Rahman TM, Hodgson JF. Review article: liver support system in acute hepatic failure. Aliment Pharmacol Ther 1999; 13: 125572.
  • 6
    Kaptanoglu L, Blei AT. Current status of liver support systems. Clin Liver Dis 2000; 4: 71129.
  • 7
    Hui T, Rozga J, Demetriou AA. Bioartificial liver support. JHepatobiliary Pancreat Surg 2001; 8: 115.
  • 8
    Watanabe FD, Mullon CJP, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase 1 clinical trial. Ann Surg 1997; 225: 48491.DOI: 10.1097/00000658-199705000-00005
  • 9
    Stevens AC, Busuttil R, Han S, et al. An interim analysis of a phase II/III prospective randomised, multicenter, controlled trial of the Hepatassist Bioartificial Liver Support System for the treatment of fulminant hepatic failure. Hepatology 2001: 34(2): 299A.
  • 10
    Morsiani E, Rozga J, Scott HC, et al. Automated liver cell processing facilitates large scale isolation and purification of porcine hepatocytes. ASAIO J 1995; 41: 15561.
  • 11
    Rozga J, Williams F, Ro MS, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993; 17: 25865.
  • 12
    Muraca M, Ghoos Y. Glyco-7-alpha,12-alpha-dihydroxy-5-beta-cholanic acid as internal standard for high-pressure liquid chromatographic analysis of conjugated bile acids. JLipid Res 1985; 26: 100911.
  • 13
    Rodriguez CM, Setchell KD. Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction. Biomed Chromatogr 1996; 10: 15.DOI: 10.1002/(SICI)1099-0801(199601)10:1<1::AID-BMC536>3.3.CO;2-V
  • 14
    Setchell KDR, Yamashita H, Rodrigues CMP, O'Connel NC, Kren BT, Steer CJ. Δ22-ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial β-oxidation as a major pathway for bile acid metabolism. Biochemistry 1995; 34: 416978.
  • 15
    Sokol RJ, Devereaux M, Khandwala R, O'Brien K. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology 1993; 17: 86981.
  • 16
    Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate induced apoptosis in rat hepatocytes. J Clin 1994; 94: 218392.
  • 17
    Benedetti A, Alvaro D, Bassotti C, et al. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile duct fragments and isolated perfused rat liver. Hepatology 1997; 26: 921.
  • 18
    Martinez-Diez MC, Serrano MA, Monte MJ, Marin JJ. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture. Biochim Biophys Acta 2000; 1500: 15360.
  • 19
    Jonsson G, Hedenborg G, Wisen O, Norman A. Serum concentrations and excretion of bile acids in cirrhosis. Scand JClin Lab Invest 1992; 52: 599605.
  • 20
    Barnes S, Gallo GA, Trash DB. Diagnostic value of serum bileacid estimations in liver disease. J Clin Pathol 1975; 28: 5069.
  • 21
    Paumgartner G. Serum bile acids: physiological determinants and results in liver disease. J Hepatol 1986; 2: 2918.
  • 22
    Von Bergmann K, Mok HY, Hardison WGM, Grundy SM. Cholesterol and bile acid metabolism in moderately advanced, stable cirrhosis of the liver. Gastroenterology 1979; 77: 118392.
  • 23
    Ponz de Leon M, Loria P, Iori R, Carulli N. Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size. Gastroenterology 1981; 80: 142837.
  • 24
    Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas–liquid chromatography–mass spectrometry: effect of ursodeoxycholic acid treatment. JLipid Res 1989; 30: 195362.
  • 25
    Siciliano M, Barbesino G, Marra L, Milani A, Rossi L. Long-term prognostic value of serum bile acids in liver cirrhosis: a prospective study. Z Gastroenterol 1989; 27: 6536.
  • 26
    Poupon RY, Poupon RE, Lebrec D, Le Quernec L, Darnis F. Mechanisms for reduced hepatic clearance and elevated plasma levels of bile acids in cirrhosis. A study in patients with an end-to-side portacaval shunt. Gastroenterology 1981; 60: 143844.
  • 27
    Azer SA, Murray M, Farrel GC, Stacey NH. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats. Hepatology 1993; 18: 122431.
  • 28
    Marigold JH, Bull HJ, Gilmore IT, Coltart DJ, Thompson RP. Direct measurement of hepatic extraction of chenodeoxycholic and ursodeoxycholic acid in man. Clin Sci 1982; 63: 197203.
  • 29
    De Caestecker JS, Jazrawi RP, Nisbett JA, Joseph AE, Maxwell JD, Northfield TC. Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease. Eur JGastroenterol Hepatol 1995; 7: 95561.
  • 30
    Patteson TE, , 3rd, Vlahcevic ZR, Schwartz CC, Gustafsson J, Danielsson H, Swell L. Bile acid metabolism in cirrhosis. VI. Sites of blockage in the bile acid pathways to primary bile acids. Gastroenterology 1980; 79: 6208.
  • 31
    Vlahcevic ZR, Buhac I, Ferrar JT. Bile acid metabolism in patients with cirrhosis. I. Kinetic aspects of cholic acid metabolism. Gastroenterology 1971; 60: 4918.
  • 32
    Vlahcevic ZR, Juttijudata P, Bell CC, Jr. Bile acid metabolisminpatients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism. Gastroenterology 1972; 62: 117481.
  • 33
    Miettinen TA. Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease. Gut 1972; 13: 6829.
  • 34
    Stiehl A, Ast E, Czygan P, Frohling W, Raedsch R, Kommerell B. Pool size, synthesis, and turnover of sulfated and nonsulfated cholic acid and chenodeoxycholic acid in patients with cirrhosis of the liver. Gastroenterology 1978; 74: 5727.
  • 35
    Carey MC, Armstrong MJ. The hydrophobic hydrophilic balance of bile salt. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol solubilizing capacities. J Lipid Res 1982; 23: 7080.
  • 36
    Hofmann AF, Roda A. Physico-chemical properties of bile acids and their relationship to biological properties: an overview of the problem. J Lipid Res 1984; 25: 147789.
  • 37
    Silva RFM, Rodrigues CMP, Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. JHepatol 2001; 34: 4028.
  • 38
    Bron B, Waldram R, Silk DB, Williams R. Serum, cerebral fluid, and brain levels of bile acids in patients with fulminant liver failure. Gut 1977; 18: 6926.
  • 39
    Morita T, Matsuyama Y, Fujimoto T, Higuchi M, Tsujii T, Matsuoka Y. Clinical significance of serum bile acid measurement in liver diseases. Gastroenterol Jpn 1978; 13: 491502.
  • 40
    Beuers U, Boyer JL, Paumgartner G. Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology 1998; 28: 144953.
  • 41
    Lauterburg BH, Dickson ER, Pineda AA, Carlson GL, Taswell HF. Removal of bile acids and bilirubin by plasmaperfusion of U.S.P. charcoal-coated glass beads. J Lab Clin Med 1979; 94: 58592.
  • 42
    O'Grady JG, Gimson AES, O'Brien CJ, Pukknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 118692.
  • 43
    Pazzi P, Scagliarini R, Puviani AC, Lodi G, Morsiani E, Gullini S. Biochemical assessment and clinical evaluation of a non-ionic adsorbent resin in patients with intractable jaundice. Int J Artif Organs 2000; 23: 3128.
  • 44
    Morsiani E, Pazzi P, Moscioni AD, Rozga J, Azzena G, Demetriou AA. In vitro morphological and functional characterization of isolated porcine hepatocytes from extracorporeal liver support: bile acid uptake and conjugation. J Surg Res 1998; 79: 5460.DOI: 10.1006/jsre.1998.5356